Tak Mak moves to breast cancer

New $125m Toronto facility could be 'Manhattan Project of cancer,' says Mak

Written byDoug Payne
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Leading Canadian researcher Tak Mak announced last week (June 2) that he will head a new breast cancer research center in Toronto. The Institute for Breast Cancer Research (IBCR), based at the Princess Margaret Hospital, will focus on three areas: identifying genes to target for future cancer therapies—including the use of transgenics and knockout mice, Drosophila screening tumor and tissue banks/human samples, signal transduction, and cancer immunotherapy; developing new surgical, radiation, and drug treatments; and expanding the number of clinical trials—40 are now underway—conducted at the hospital.

The announcement garnered widespread support from international colleagues.

"The institute," wrote Jean-François Bach, the past president of the Necker Hospital in Paris, "represents a unique opportunity." Hans Wigzell, the former chair of the Nobel Prize Committee in Stockholm, said the facility, would likely be "a significant contributor in the global arena in the fight against this disease."

The IBCR hopes to raise CDN ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Skip the Wait for Protein Stability Data with Aunty

Skip the Wait for Protein Stability Data with Aunty

Unchained Labs

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform